Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery
Saved in:
| Title: | Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery |
|---|---|
| Authors: | Exscientia plc |
| Source: | Business Wire (English). 07/10/2024. |
| Abstract: | Exscientia plc (Nasdaq: EXAI) today announced it will be expanding its work with Amazon Web Services (AWS) to use the cloud provider’s artificial intelligence (AI) and machine learning (ML) services to power its platform for end-to-end drug discovery and automation. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Exscientia plc (Nasdaq: EXAI) today announced it will be expanding its work with Amazon Web Services (AWS) to use the cloud provider’s artificial intelligence (AI) and machine learning (ML) services to power its platform for end-to-end drug discovery and automation. [ABSTRACT FROM PUBLISHER] |
|---|
